Article
A heterozygous <i>CEBPA</i> mutation disrupting the bZIP domain causes MDS disease progression
2023-07-26
Abstract excerpt
<h4>SUMMARY</h4> Myelodysplastic syndrome disease (MDS) has a variable risk for progression to AML. Mutations in CEBPA are associated with a high risk of disease progression, but whether this mutation is causative for AML development is unclear. To answer this question, we generated patient-derived, MDS-specific iPSCs recapitulating the patient disease phenotype upon differentiation to blood, with hematopoietic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8f5022e6-4314-5350-836d-c26118ed74f4
- DOI
- 10.1101/2023.07.24.550349
